During his tenure at Y-mAbs Therapeutics, Dr. Claus Møller held a significant amount of stock options. By 2021, he had options for 500,000 shares at an exercise price of $2.00 and another 275,000 shares at $30.34. However, after stepping down...
During his tenure at Y-mAbs Therapeutics, Dr. Claus Møller held a significant amount of stock options. By 2021, he had options for 500,000 shares at an exercise price of $2.00 and another 275,000 shares at $30.34. However, after stepping down in April 2022, the value of his holdings started to fluctuate. In 2021, Dr. Møller's potential wealth was quite high due to these stock options, reflecting confidence in the company's future. His holdings were closely tied to the performance of Y-mAbs, which focuses heavily on innovative cancer therapies. While he exited Y-mAbs amidst changes in leadership, the worth of these options depended on the company's stock market performance moving forward. Dr. Møller's financial interests remained engaged with the growth of the company long after his departure.